Management of nasal atrophy.
D006801:Humans; D008443:Maxillary Sinus; D010205:Pantothenic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D011343:Procaine / Q000008:administration & dosage / Q000627:therapeutic use*; D012222:Rhinitis, Atrophic / Q000188:drug therapy*
D010205:Pantothenic Acid; D011343:Procaine